NMP

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameNMP
Drug Alias NameNMPN-methyl-2-pyrrolidoneN-methylpyrrolidone
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterferon regulatory factor 4 inhibitors
TargetsInterferon regulatory factor 4
Therapy Area/IndicationsHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPeter Maccallum Cancer Centre
China Registration ClassN/A

Develop Information

Active CompaniesPeter Maccallum Cancer Centre
Inactive CompaniesN/A
Active IndicationsHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A